凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

未开盘 07-22 16:08:03

118.900

-3.500

-2.86%

最高125.300	最低118.200	成交量77.35万
今开123.200	昨收122.400	日振幅5.80%
总市值429.23亿	流通市值32.76亿	总股本3.61亿
成交额9,389万	换手率2.81%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":118.9,"timestamp":1784707683011,"preClose":122.4,"halted":0,"volume":773500,"delay":0,"changeRate":-0.028594771241830064,"floatShares":27553260,"shares":361000000,"eps":3.6572702037231624,"marketStatus":"未开盘","change":-3.5,"latestTime":"07-22 16:08:03","open":123.2,"high":125.3,"low":118.2,"amount":93886392,"amplitude":0.058007,"askPrice":118.9,"askSize":500,"bidPrice":118.3,"bidSize":300,"shortable":3,"etf":0,"ttmEps":3.597064129040352,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784770200000},"marketStatusCode":0,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":122.4,"dividendRate":0.01262,"openAndCloseTimeList":[[1784683800000,1784692800000],[1784696400000,1784707200000]],"volumeRatio":0.631177,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":164.28,"timestamp":1784703600000,"preClose":169.5,"halted":0,"volume":12268900,"delay":0,"premium":"-37.46"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2653784170","title":"凯莱英获小摩增持18.595万股 每股作价约130.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784170","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653784170?lang=zh_cn&edition=full","pubTime":"2026-07-22 08:30","pubTimestamp":1784680200,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，7月16日，小摩增持凯莱英（06821）18.595万股，每股作价130.859港元，总金额约为2433.32万港元。增持后最新持股数目约为234.71万股，最新持股比例为8.43%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-22/doc-iniirshq4735285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0106261372.USD","IE00BJLML261.HKD","KBWB","JPO","LU2430703095.HKD","BK4566","LU2244417387.USD","FTXO","LU2213496289.HKD","06821","LU0345769128.USD","TRUF","BK1191","002821","TFNS","LU0976567544.SGD","IXG","LU2237443465.HKD","JPX","LU0820561909.HKD","LU1496350502.SGD","SG9999002232.USD","FNCL","LU1116320901.HKD","LU0417517546.SGD","BK4207","IE000M9KFDE8.USD","LU0070302665.USD","LU0265550946.USD","IYG","LU0640476718.USD","LU2552382058.USD","LU2106854487.HKD","BK4588","UYG","VFH","LU2505996509.AUD","LU1894683264.USD","IE00BDRTCR15.USD","LU0256863902.USD","LU2456880835.USD","LU2746668461.USD","IYF","LU2592432038.USD","EWH","LU0683600562.USD","LU1363072403.SGD","LU2264538146.SGD","JPMO","XLF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653209039","title":"谭冬寒2026年二季度表现，工银兴瑞一年持有期混合A基金季度涨幅3.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653209039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653209039?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:52","pubTimestamp":1784649130,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理谭冬寒旗下共管理9只基金，本季度表现最佳的为工银兴瑞一年持有期混合A，季度净值涨3.65%。持有期间的估算收益率为94.05%，持有期间博腾股份在2021年到2022年的年报归属净利润增幅达282.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100046076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271093","title":"小摩增持凯莱英(06821.HK)18.595万股 每股作价约130.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271093","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653271093?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:15","pubTimestamp":1784632536,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652147400","title":"Norges Bank减持凯莱英(06821.HK)20.19万股 每股作价约133.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652147400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652147400?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:13","pubTimestamp":1784286820,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406625","title":"7月17日凯莱英跌10.00%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652406625?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:45","pubTimestamp":1784277957,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日凯莱英跌10.00%，收盘报161.99元，换手率3.99%，成交量12.65万手，成交额20.88亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A目前规模为1.97亿元，最新净值1.4311，较上一交易日下跌2.24%，近一年上涨3.51%。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","LU1328615791.USD","002821","BK1191","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652747246","title":"凯莱英(06821)AH齐跌 NorgesBank持股比例降至7.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652747246","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652747246?lang=zh_cn&edition=full","pubTime":"2026-07-17 13:36","pubTimestamp":1784266605,"startTime":"0","endTime":"0","summary":"金吾财讯 | 凯莱英(06821)盘中持续走低，午后跌幅进一步扩大，截至发稿，最新报1125.20港元，跌幅10.49%，成交额7529.75万港元。对应A股(002821)同步下跌9.99%，最新报161.99元人民币，成交额18.53亿元人民币。消息面上，港交所新近文件披露，NorgesBank已于7月14日减持凯莱英20.76万股，每股均价127.6543港元，涉资约2650.1万港元。减持后，NorgesBank最新持股数目为206.06万股，持股比例由8.15%下降至7.40%。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986142","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0239","BK0132","06821","BK1191","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122104055","title":"异动解读｜凯莱英盘中下跌5.05%，外资机构连续减持叠加制药板块整体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1122104055","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122104055?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:01","pubTimestamp":1784253695,"startTime":"0","endTime":"0","summary":"7月17日，凯莱英盘中下跌5.05%，报118.9港元，成交额3732.78万港元。消息面上，多家外资机构近期持续减持凯莱英港股。Schroders PLC于7月15日再度减持20.80万股，每股作价约132.76港元，持股比例降至12.66%；此前该机构已于7月9日及7月14日分别减持13.1万股和30.27万股。此外，公司A股此前连续两次触发交易异常波动，累计涨幅显著，短期获利盘压力较大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449196","title":"凯莱英(06821.HK)两股东同日减持合计逾51.03万股 涉资6487.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449196","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651449196?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:17","pubTimestamp":1784200668,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449909","title":"Schroders PLC减持凯莱英(06821)20.80万股 每股作价约132.76港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449909","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651449909?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:15","pubTimestamp":1784200535,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月15日，Schroders PLC减持凯莱英(06821)20.80万股，每股作价132.7607港元，总金额约2761.42万港元。减持后最新持股数目约为352.45万股，持股比例为12.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","06821","BK1191","LU1328615791.USD","002821","EWH","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651502294","title":"凯莱英(06821.HK)：A股股票交易异常波动 不存在应披露而未披露重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2651502294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651502294?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:56","pubTimestamp":1784116585,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146812","title":"凯莱英：公司A股股票交易异常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146812","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651146812?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:55","pubTimestamp":1784116500,"startTime":"0","endTime":"0","summary":"南财智讯7月15日电，凯莱英（002821）公告，公司股票于2026年7月13日至7月15日连续三个交易日内收盘价格涨幅偏离值累计超过20%，根据深圳证券交易所相关规定，属于股票交易异常波动情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807657675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0132","002821","BK1191","159982","BK0239","399300","LU1328615791.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468515","title":"小摩减持凯莱英(06821.HK)5.74万股 每股作价约115.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468515","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651468515?lang=zh_cn&edition=full","pubTime":"2026-07-15 19:47","pubTimestamp":1784116065,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06821","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453715","title":"7月15日凯莱英涨10.00%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651453715?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:31","pubTimestamp":1784104299,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日凯莱英涨10.00%创60日新高，收盘报195.75元，换手率7.09%，成交量22.47万手，成交额42.4亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK0132","BK0239","BK1191","06821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157486541","title":"异动解读｜凯莱英盘中上涨5.96%，CXO板块持续反弹叠加机构看多共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1157486541","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157486541?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:47","pubTimestamp":1784080036,"startTime":"0","endTime":"0","summary":"7月15日，凯莱英盘中上涨5.96%，报131.8港元，成交额7163.63万港元。消息面上，CXO板块延续强势反弹。近日野村证券将凯莱英目标价由115.43港元上调至131.48港元，维持买入评级，核心逻辑为GLP-1受体促效剂全球扩展持续利好CXO产业链；摩根大通于7月7日增持凯莱英14.38万股，持股比例升至9.17%。行业层面，自6月8日至7月10日CRO指数已反弹21.72%，随着中期业绩临近及二季度订单趋势明确，CXO反弹有望获得业绩支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651173065","title":"7月14日凯莱英涨7.63%，红土创新医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651173065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651173065?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:28","pubTimestamp":1784017728,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日凯莱英涨7.63%，收盘报177.95元，换手率5.69%，成交量18.05万手，成交额30.66亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为红土创新基金的红土创新医疗保健股票A。红土创新医疗保健股票A目前规模为1.97亿元，最新净值1.3931，较上一交易日下跌2.14%，近一年上涨5.34%。红土创新医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1328615791.USD","06821","BK1191","BK0132","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651272331","title":"港股异动 | CRO概念股今日普涨 内外需求共振行业向好 机构称CXO反弹具有业绩支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2651272331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651272331?lang=zh_cn&edition=full","pubTime":"2026-07-14 14:48","pubTimestamp":1784011706,"startTime":"0","endTime":"0","summary":"据报道称，当前食蟹猴身价已突破20万元。华鑫证券研报认为，从6月初至今，CXO板块在业绩和订单的支撑下，率先于创新药反弹。自6月8日至7月10日，CRO指数已反弹21.72%。展望下半年，创新药融资增长将继续支持CXO景气度延续。目前CRO龙头企业药明康德2027年预测PE为17.58X，凯莱英为33.19X。随着中期业绩临近，2季度订单趋势逐步明确，CXO反弹有望获得业绩支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","LU1046422090.SGD","BK4588","LU2242644610.SGD","BK1191","LU0708995583.HKD","03759","LU2045819591.USD","BK1583","LU0052750758.USD","LU0320764599.SGD","BK1576","CXO","02359","BK1141","VXUS","KCAI","LU0348766576.USD","06127","LU2125910500.SGD","BK4585","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144880773","title":"异动解读｜凯莱英盘中上涨5.01%，野村上调目标价叠加摩根大通增持延续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1144880773","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144880773?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:55","pubTimestamp":1783997723,"startTime":"0","endTime":"0","summary":"7月14日，凯莱英盘中上涨5.01%，报127.8港元，成交额4791.6万港元。消息面上，近日多重利好持续发酵。野村证券将凯莱英目标价由115.43港元上调至131.48港元，维持\"买入\"评级，核心逻辑为GLP-1受体促效剂在全球市场的大幅扩展将持续利好CXO产业链。同时，摩根大通于7月7日增持凯莱英14.38万股，每股作价约111.63港元，增持后持股比例升至9.17%，总金额约1605.27万港元。当前股价已突破野村新目标价附近区域，机构看多信号叠加外资加仓形成共振，市场做多情绪延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651386126","title":"医药外包概念股普涨 凯莱英(06821)升逾4% 机构指CXO反弹有望获业绩支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2651386126","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651386126?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:51","pubTimestamp":1783997504,"startTime":"0","endTime":"0","summary":"2026年Q2Orforglipron等外企重磅品种获批上市，继续支撑药明康德订单增长。药明康德主动回购也彰显对未来信心，截止2026年6月25日，已回购金额超过10亿元。从6月初至今，CXO板块在业绩和订单的支撑下，率先于创新药反弹。自6月8日至7月10日，CRO指数已反弹21.72%。展望下半年，创新药融资增长将继续支持CXO景气度延续。目前CRO龙头企业药明康德2027年预测PE为17.58X，凯莱英为33.19X。随着中期业绩临近，2季度订单趋势逐步明确，CXO反弹有望获得业绩支撑。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985793","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0979878070.USD","LU0708995583.HKD","03347","LU0516423091.SGD","LU0516423174.USD","IE00B0JY6N72.USD","02269","BK1161","BK0239","03759","BK1576","BK1521","BK1515","LU0326950275.SGD","CXO","KURE","LU0348735423.USD","LU1688375341.USD","LU0516422952.EUR","LU0823426480.USD","BK1583","LU1720050803.USD","09939","LU0051755006.USD","LU0516422366.SGD","LU2045819591.USD","LU2125910500.SGD","LU1242518857.USD","LU0456827905.SGD","06821","LU1046422090.SGD","LU0039217434.USD","159938","LU0417516738.SGD","SG9999002463.SGD","02359","LU1794554557.SGD","06127","BK1191","002821","BK0132","LU0043850808.USD","LU0327786744.USD","LU0348825331.USD","BK1574","LU0456846285.SGD","LU0181495838.USD","LU2242644610.SGD","LU3063872942.SGD","LU0856984785.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116977","title":"Schroders PLC减持凯莱英(06821)13.1万股 每股作价约114港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116977","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651116977?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:21","pubTimestamp":1783941676,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，7月9日，Schroders PLC减持凯莱英(06821)13.1万股，每股作价114.0024港元，总金额约为1493.43万港元。减持后最新持股数目为416.81万股，最新持股比例为14.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","BK0239","EWH","BK1191","06821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182203576","title":"异动解读｜凯莱英盘中上涨5.91%，野村上调目标价叠加小摩增持提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1182203576","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182203576?lang=zh_cn&edition=full","pubTime":"2026-07-13 10:02","pubTimestamp":1783908152,"startTime":"0","endTime":"0","summary":"7月13日，凯莱英盘中上涨5.91%，报129.3港元，成交额4957.79万港元。消息面上，近日多重利好共振。野村证券将凯莱英目标价由115.43港元上调至131.48港元，维持\"买入\"评级，核心逻辑为GLP-1受体促效剂在全球市场的大幅扩展将持续利好CXO产业链。同时，摩根大通于7月7日增持凯莱英14.38万股，每股作价约111.63港元，增持后持股比例升至9.17%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":-0.1107},{"period":"1month","weight":0.2389},{"period":"3month","weight":0.3096},{"period":"6month","weight":0.4083},{"period":"1year","weight":0.2783},{"period":"ytd","weight":0.6931}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0473},{"period":"3month","weight":-0.0395},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0094},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058449},{"month":2,"riseRate":0.4,"avgChangeRate":0.006895},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036171},{"month":5,"riseRate":0.4,"avgChangeRate":0.006805},{"month":6,"riseRate":0.6,"avgChangeRate":0.053806},{"month":7,"riseRate":0.6,"avgChangeRate":0.070453},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064095},{"month":9,"riseRate":0.75,"avgChangeRate":0.163213},{"month":10,"riseRate":0,"avgChangeRate":-0.125552},{"month":11,"riseRate":0.5,"avgChangeRate":0.010601},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010173}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}